135 related articles for article (PubMed ID: 36384804)
1. Dummy run quality assurance study in the Korean Radiation Oncology Group 19 - 09 multi-institutional prospective cohort study of breast cancer.
Kim M; Park B; Kim H; Kim YJ; Choi DJ; Chung W; Kim YJ; Shin HS; Im JH; Suh CO; Kim JH; Ha B; Kim MY; Park J; Lee J; Ahn SJ; Lee SY; Kusumawidjaja G; Lim F; Cho WK; Kim H; Choi DH; Park W
Radiat Oncol; 2022 Nov; 17(1):186. PubMed ID: 36384804
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701).
Kim H; Kim H; Park W; Baek JY; Ahn SJ; Kim MY; Park SH; Lee IJ; Ha I; Kim JH; Kim TH; Lee KC; Lee HS; Kim TG; Kim JH; Lee JH; Jung J; Cho O; Chang JS; Kim ES; Jo IY; Koo T; Kim K; Park HJ; Shin YJ; Ha B; Kwon J; Lee JH; Moon S
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158245
[TBL] [Abstract][Full Text] [Related]
3. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
[TBL] [Abstract][Full Text] [Related]
4. Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study.
Chung E; Noh JM; Lee KC; Kim JH; Chung WK; Suh YG; Lee JA; Seol KH; Wu HG; Kim YS; Noh OK; Park JW; Lee DS; Lee J; Kim YS; Park WY; Kang MK; Jo S; Ahn YC
Cancer Res Treat; 2019 Jul; 51(3):1001-1010. PubMed ID: 30322229
[TBL] [Abstract][Full Text] [Related]
5. Mapping of Level I Axillary Lymph Nodes in Patients with Newly Diagnosed Breast Cancer: Optimal Target Delineation and Treatment Techniques for Breast and Level I Axilla Irradiation.
Zhao XR; Guo N; Ma C; Yan XN; Tang Y; Jing H; Fang H; Li YX; Li J; Wang SL
Pract Radiat Oncol; 2022; 12(6):487-495. PubMed ID: 35247622
[TBL] [Abstract][Full Text] [Related]
6. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
Haussmann J; Budach W; Tamaskovics B; Bölke E; Corradini S; Djiepmo-Njanang FJ; Kammers K; Matuschek C
Radiat Oncol; 2019 Jun; 14(1):102. PubMed ID: 31186015
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.
Bae SH; Kim MS; Jang WI; Kim KB; Cho KH; Kim WC; Lee CY; Kim ES; Choi CW; Chang AR; Jo S; Kim JY
Jpn J Clin Oncol; 2017 Jun; 47(6):535-542. PubMed ID: 28419246
[TBL] [Abstract][Full Text] [Related]
8. [Dosimetric comparison of external partial breast irradiation with whole breast irradiation and partial breast brachytherapy].
Bodács I; Polgár C; Major T
Magy Onkol; 2014 Jun; 58(2):108-15. PubMed ID: 25010759
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials.
Qi WX; Cao L; Xu C; Zhao S; Chen J
Breast; 2020 Feb; 49():165-170. PubMed ID: 31812892
[TBL] [Abstract][Full Text] [Related]
11. Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network-Can We Translate Results From Randomized Trials Into the Clinic?
Ling DC; Moppins BL; Champ CE; Gorantla VC; Beriwal S
Pract Radiat Oncol; 2021; 11(1):e30-e35. PubMed ID: 32615162
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer.
Kim Y; Parda DS; Trombetta MG; Colonias A; Werts ED; Miller L; Miften M
Med Phys; 2007 Dec; 34(12):4640-8. PubMed ID: 18196791
[TBL] [Abstract][Full Text] [Related]
13. Individualised target volume selection and dose prescription after conservative surgery, mastectomy and reconstruction.
Chua BH
Breast; 2019 Nov; 48 Suppl 1():S69-S75. PubMed ID: 31839165
[TBL] [Abstract][Full Text] [Related]
14. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
15. Inter-institutional Variation in Intensity-modulated Radiotherapy for Breast Cancer in Korea (KROG 19-01).
Kim K; Chun M; Jin H; Jung W; Shin KH; Shin SS; Kim YJ; Park SH; Kim JH; Kim YH; Shin HS; Kim H; Kim SS; Lee JH; Kim YB; Lee SY; Choi J; Oh DH; Kang KM; Kwon J; Kim MY; Koo T; Park HJ; Ahn SJ
Anticancer Res; 2021 Jun; 41(6):3145-3152. PubMed ID: 34083309
[TBL] [Abstract][Full Text] [Related]
16. The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC; Pepa M; Luraschi R; Vigorito S; Dicuonzo S; Isaksson LJ; La Porta MR; Marino L; Ippolito E; Huscher A; Argenone A; De Rose F; Cucciarelli F; De Santis MC; Rossi F; Prisco A; Guarnaccia R; Tabarelli de Fatis P; Palumbo I; Colangione SP; Mormile M; Ravo V; Fozza A; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA;
Radiother Oncol; 2022 Mar; 168():113-120. PubMed ID: 35033602
[TBL] [Abstract][Full Text] [Related]
17. Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation. A dosimetric comparison in adjuvant radiotherapy of early stage breast cancer.
Würschmidt F; Stoltenberg S; Kretschmer M; Petersen C
Strahlenther Onkol; 2014 Jun; 190(6):563-8. PubMed ID: 24604557
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies.
Badiyan SN; Shah C; Arthur D; Khan AJ; Freedman G; Poppe MM; Vicini FA
Radiother Oncol; 2014 Jan; 110(1):39-44. PubMed ID: 24440047
[TBL] [Abstract][Full Text] [Related]
20. Volumetric arc therapy: A viable option for right-sided breast with comprehensive regional nodal irradiation in conjunction with deep inspiration breath hold.
Holt E; Mantel A; Cokelek M; Tacey M; Jassal S; Law M; Zantuck N; Yong C; Cheng M; Viotto A; Foroudi F; Chao M
J Med Imaging Radiat Sci; 2021 Jun; 52(2):223-237. PubMed ID: 33771509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
